These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 33025153)

  • 1. Liver fat quantification: where do we stand?
    Starekova J; Reeder SB
    Abdom Radiol (NY); 2020 Nov; 45(11):3386-3399. PubMed ID: 33025153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
    Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
    Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
    Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiologic evaluation of nonalcoholic fatty liver disease.
    Lee SS; Park SH
    World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease.
    Lee SJ; Kim SU
    Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):523-530. PubMed ID: 31018719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
    Arulanandan A; Ang B; Bettencourt R; Hooker J; Behling C; Lin GY; Valasek MA; Ix JH; Schnabl B; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1513-20.e1. PubMed ID: 25661453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
    Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
    Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease.
    Schaapman JJ; Tushuizen ME; Coenraad MJ; Lamb HJ
    J Magn Reson Imaging; 2021 Jun; 53(6):1623-1631. PubMed ID: 32822095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L; Friedrich-Rust M; Loomba R
    Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Park SJ
    Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
    Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
    Pirmoazen AM; Khurana A; Loening AM; Liang T; Shamdasani V; Xie H; El Kaffas A; Kamaya A
    Invest Radiol; 2022 Jan; 57(1):23-32. PubMed ID: 34049335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.
    Denimal D; Béland-Bonenfant S; Pais-de-Barros JP; Rouland A; Bouillet B; Duvillard L; Vergès B; Petit JM
    Cardiovasc Diabetol; 2023 Nov; 22(1):310. PubMed ID: 37940926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease.
    Imajo K; Honda Y; Yoneda M; Saito S; Nakajima A
    J Med Ultrason (2001); 2020 Oct; 47(4):535-548. PubMed ID: 33108553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography.
    Tada T; Nishimura T; Yoshida M; Iijima H
    J Med Ultrason (2001); 2020 Oct; 47(4):511-520. PubMed ID: 33089412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.
    Lemoine M; Assoumou L; De Wit S; Girard PM; Valantin MA; Katlama C; Necsoi C; Campa P; Huefner AD; Schulze Zur Wiesch J; Rougier H; Bastard JP; Stocker H; Mauss S; Serfaty L; Ratziu V; Menu Y; Schlue J; Behrens G; Bedossa P; Capeau J; Ingiliz P; Costagliola D;
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e86-e94. PubMed ID: 30570529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.
    Caussy C; Reeder SB; Sirlin CB; Loomba R
    Hepatology; 2018 Aug; 68(2):763-772. PubMed ID: 29356032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.
    Han A; Byra M; Heba E; Andre MP; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
    Radiology; 2020 May; 295(2):342-350. PubMed ID: 32096706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.
    Tamaki N; Ajmera V; Loomba R
    Nat Rev Endocrinol; 2022 Jan; 18(1):55-66. PubMed ID: 34815553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.